TrialJAMA network open2024

Bone-Modifying Agents in Patients With High-Risk Metastatic Castration-Sensitive Prostate Cancer Treated With Abiraterone Acetate.

Wataru Fukuokaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.